Shared gains for switching biosimilars

21/03/2022/in My presentations /by ignacioriesgo

See PDF of the presentation:

Presentación Barcelona 15 marzo, 2022

On March 15, 2022, jointly organized by BIOSIM and the Consorci Social y Sanitario de Catalunya, a session on shared gains took place. In the course of this session I had the opportunity to make the attached presentation on shared gains for biosimilar switching (going from originator biologics to biosimilars).

Últimas entradas

7 days in healthcare (April 8th-14th, 2024)14/04/2024 - 21:02
Summary From the point of view of Biomedicine, chatbots (devices that interact by text or voice with people based on artificial intelligence), are increasingly used in healthcare. In the UK, the NHS uses them in Primary Care to triage patients. One of the great challenges of future health management is determining what will be done […]
7 days in healthcare (April, 1st-7th, 2024)07/04/2024 - 21:29
Summary From the point of view of Biomedicine, the report published by the French National Academy of Medicine on generative AI systems in health is worth highlighting. It makes 10 recommendations, the first of which is that all health professionals should be trained in the use of generative AI. It seems that anti-obesity medications […]
7 days in healthcare (March 25th-31st, 2024)31/03/2024 - 21:27
Summary From the point of view of Biomedicine, it should be noted that possibly the next “boom” will be everything related to anti-aging therapies, an aspect to which the Financial Times dedicates an article, following the appearance of three books on the subject. . The Economist dedicates a lot of space in its latest […]

You might also like